Trial record 1 of 1 for:    NCT01769885
Previous Study | Return to List | Next Study

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborators:
AVEO Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01769885
First received: January 15, 2013
Last updated: December 17, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)